Olig2 antibody labels nuclear tumor cells in oligodendroglioma of brain.
Olig2 (211F1.1) Mouse Monoclonal Antibody
Specialties: Neuropathology
Updated: 2017-05-24 08:46:09
Olig2, a basic helix–loop–helix transcription factor, is involved in oligodendroglial specification. Olig2 expression has been reported in most glial tumors, such as oligodendrogliomas and astrocytomas.1-2
- Mokhtari K, et al. Olig2 expression, GFAP, p53 and 1p loss analysis contribute to glioma subclassification. Neuropathol Appl Neurobiol. 2005; 31:62-9.
- Otero JJ, et al. OLIG2 is differentially expressed in pediatric astrocytic and in ependymal neoplasms. J Neurooncol. 2011; 104:423-38.
Specifications
- Reactivity: paraffin
- Visualization: nuclear
- Control: astrocytoma
- Dilution Range: 1:25-1:100*
Package Inserts
IFU
- IVD Rev. 2.0 (CMC38721020)
Have a different keycode?
Click Here
Learn how to obtain your SDS
Ordering Information
For in vitro diagnostic (IVD) use in USA
| 0.1 mL concentrate | 387M-14 |
| 0.5 mL concentrate | 387M-15 |
| 1 mL concentrate | 387M-16 |
| 1 mL predilute | 387M-17 |
| 7 mL predilute | 387M-18 |
For in vitro diagnostic (IVD) use in Canada
| 0.1 mL concentrate | 387M-14 |
| 0.5 mL concentrate | 387M-15 |
| 1 mL concentrate | 387M-16 |
| 1 mL predilute | 387M-17 |
| 7 mL predilute | 387M-18 |
For in vitro diagnostic (IVD) use in Europe
| 0.1 mL concentrate | 387M-14 |
| 0.5 mL concentrate | 387M-15 |
| 1 mL concentrate | 387M-16 |
| 1 mL predilute | 387M-17 |
| 7 mL predilute | 387M-18 |
This product is not available in Japan
To request information on this product in additional countries, please click the button below.
